Literature DB >> 410697

Role of biliary lecithin in lymphatic transport of fat.

P Tso, J A Balint, W J Simmonds.   

Abstract

This study was undertaken to asses the role of luminal lecithin in the lymphatic transportation of fat as chylomicrons. Two doses of fat, the low and high dose, were fed to two different groups of rats, control and bile fistula. At low dose, infusing at 35 mumoles of total fatty acid per hr of a mixture of oleic acid and monoolein, molar ratio 2:1, solubilized in 55 mumoles of sodium taurocholate, there was no difference in the lymphatic output of absorbed fat during steady state (7th and 8th hour) absorption. Infusing at a high dose, 173 mumoles of total fatty acid per hr of a mixture of oleic acid and monoolein, molar ratio 2:1, solubilized in 55 mumoles of sodium taurocholate, the bile fistula rats had lower triglyceride and phospholipid output, with a higher proportion of oleic acid in lymph lecithin than did control rats. These alterations in bile fistula rats returned to normal by addding 10 mumoles per hr of biliary lecithin to the infusate. We conclude that intraluminal biliary lecithin plays a significant role in the translocation of high doses of absorbed fat into lymph and in the amount and type of lecithin synthesized.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410697

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

Review 1.  Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids.

Authors:  G J Nelson; R G Ackman
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

2.  Bile increases intestinal lymphatic drug transport in the fasted rat.

Authors:  Natalie L Trevaskis; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

3.  An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to rats.

Authors:  Natalie L Trevaskis; Chun Min Lo; Li Yun Ma; Patrick Tso; Helen R Irving; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Dietary and biliary phosphatidylcholine activates PKCζ in rat intestine.

Authors:  Shahzad Siddiqi; Charles M Mansbach
Journal:  J Lipid Res       Date:  2015-02-24       Impact factor: 5.922

5.  Dietary long-chain PUFA in the form of TAG or phospholipids influence lymph lipoprotein size and composition in piglets.

Authors:  Laura Amate; Angel Gil; María Ramírez
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

6.  The absorption and transport of dietary cholesterol in the presence of peanut oil or randomized peanut oil.

Authors:  P Tso; G Pinkston; D M Klurfeld; D Kritchevsky
Journal:  Lipids       Date:  1984-01       Impact factor: 1.880

7.  Effect of lecithin on jejunal absorption of micellar lipids in man and on their monomer activity in vitro.

Authors:  H V Ammon; P J Thomas; S F Phillipis
Journal:  Lipids       Date:  1979-04       Impact factor: 1.880

8.  Absorption of triglycerides with defined or random structure by rats with biliary and pancreatic diversion.

Authors:  M S Christensen; A Müllertz; C E Høy
Journal:  Lipids       Date:  1995-06       Impact factor: 1.880

9.  Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley rats.

Authors:  Linda S Zhang; Hirokazu Sato; Qing Yang; Robert O Ryan; David Q-H Wang; Philip N Howles; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-01       Impact factor: 4.052

10.  Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet.

Authors:  Bo Wang; Xin Rong; Mark A Duerr; Daniel J Hermanson; Per Niklas Hedde; Jinny S Wong; Thomas Q de Aguiar Vallim; Benjamin F Cravatt; Enrico Gratton; David A Ford; Peter Tontonoz
Journal:  Cell Metab       Date:  2016-01-28       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.